Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Gamida Cell Ltd. | 855,461 | reported | 31 Jan 2024 | tx 5+798,079 |
| CG Oncology, Inc. | 119,922 | reported | 15 Apr 2025 | tx 3+267,697 |
| AKCEA THERAPEUTICS, INC. | 0 | reported | 12 Oct 2020 | tx 9+23,780−48,699 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Apr 2025 | GRANT_AWARD | CG Oncology, Inc. | 119,922 | 0.00 USD | deriv |
| 04 Oct 2024 | GRANT_AWARD | CG Oncology, Inc. | 47,775 | 0.00 USD | deriv |
| 15 May 2024 | GRANT_AWARD | CG Oncology, Inc. | 100,000 | 0.00 USD | deriv |
| 31 Jan 2024 | GRANT_AWARD | Gamida Cell Ltd. | 480,319 | 0.00 USD | |
| 08 Feb 2023 | GRANT_AWARD | Gamida Cell Ltd. | 63,000 | 0.00 USD | |
| 08 Feb 2023 | GRANT_AWARD | Gamida Cell Ltd. | 125,860 | 0.00 USD | deriv |
| 28 Jan 2022 | GRANT_AWARD | Gamida Cell Ltd. | 51,000 | 0.00 USD | |
| 28 Jan 2022 | GRANT_AWARD | Gamida Cell Ltd. | 77,900 | 0.00 USD | deriv |
| 12 Oct 2020 | TENDER | AKCEA THERAPEUTICS, INC. | 26,532 | 18.15 USD | |
| 12 Oct 2020 | OTHER | AKCEA THERAPEUTICS, INC. | 13,750 | 1.16 USD | deriv |
| 12 Oct 2020 | OTHER | AKCEA THERAPEUTICS, INC. | 7,500 | 5.39 USD | deriv |
| 22 Sept 2020 | SALE | AKCEA THERAPEUTICS, INC. | 319 | 18.12 USD | |
| 17 Jul 2020 | SALE | AKCEA THERAPEUTICS, INC. | 263 | 12.50 USD | |
| 15 Apr 2020 | GRANT_AWARD | AKCEA THERAPEUTICS, INC. | 12,500 | 0.00 USD | |
| 23 Mar 2020 | SALE | AKCEA THERAPEUTICS, INC. | 335 | 11.76 USD | |
| 19 Mar 2020 | GRANT_AWARD | AKCEA THERAPEUTICS, INC. | 3,780 | 0.00 USD | |
| 19 Mar 2020 | GRANT_AWARD | AKCEA THERAPEUTICS, INC. | 7,500 | 0.00 USD | deriv |